Co-Diagnostics Inc.

NASDAQ: CODX · Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM

Co-Diagnostics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-37.64M -35.33M -14.24M 36.66M
Depreciation & Amortization
1.38M 1.23M 1.28M 335.36K
Stock-Based Compensation
5.43M 8.34M 7.54M 5.51M
Other Working Capital
144.92K 922.89K -2.58M 438.98K
Other Non-Cash Items
-1.08M 460.32K 10.42M 544.46K
Deferred Income Tax
n/a -2.42M -4.81M 930.08K
Change in Working Capital
2.75M 5.64M 6.37M -2.9M
Operating Cash Flow
-29.16M -22.08M 6.57M 41.08M
Capital Expenditures
-748.35K -1.37M -1.43M -669.46K
Cash Acquisitions
n/a n/a 1.59K 1.69M
Purchase of Investments
-40.8M -110.5M -68M -491.74K
Sales Maturities Of Investments
58.77M 127.25M 11.26M 3.08M
Other Investing Acitivies
-143.75K n/a -1.59K 491.74K
Investing Cash Flow
17.07M 15.39M -58.17M 4.1M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -1.36M -14.21M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 450.4K
Financial Cash Flow
103.91K -1.36M -14.03M 450.4K
Net Cash Flow
-11.98M -8.06M -65.63M 45.63M
Free Cash Flow
-29.9M -23.45M 5.14M 40.41M